Skip to main content
. Author manuscript; available in PMC: 2013 May 14.
Published in final edited form as: Biomacromolecules. 2012 Apr 27;13(5):1438–1447. doi: 10.1021/bm300150q

Figure 1.

Figure 1

(A) Schematic representation of binding of the proposed polyvalent inhibitors to gp120 in the envelope glycoprotein spikes that are exposed on the surface of the HIV-1 virion. The dimensions of the spike proteins are described in Ref 38 and the dimensions of HIV-1 as well as the spacing of spikes is derived from Ref 6. (B) Schematic outline of the synthesis of the proposed side chain CDR H3 peptide-synthetic polymer inhibitors.